Insight

Latest California Healthline Stories

As California’s Behavioral Health Workforce Buckles, Help Is Years Away

California has put a greater focus on behavioral health workers, but a huge spike in demand, an aging workforce, and employee burnout continue to hamper mental health and substance use treatment. The state is tapping Medicaid funds to train, recruit, and retain workers, but it will be a long time before the impacts are evident.

California Looked to Them To Close Health Disparities, Then It Backpedaled

A statewide initiative to formalize the role of community health workers and expand their ranks was meant to improve the health of underserved communities, particularly Hispanic populations, who often experience higher rates of chronic illnesses. But years in, California has abandoned a certification program and rescinded public support.

KFF Health News' 'What the Health?': The Senate Saves PEPFAR Funding — For Now

The Senate narrowly approved the Trump administration’s request to claw back about $9 billion for foreign aid and public broadcasting but refused to cut funding for the international AIDS/HIV program PEPFAR. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other FDA-approved drugs. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.

Vested Interests. Influence Muscle. At RFK Jr.’s HHS, It’s Not Pharma. It’s Wellness.

Health and Human Services Secretary Robert F. Kennedy Jr. lambasted federal agencies he accused of being overly influenced by the pharmaceutical industry. But he and other “Make America Healthy Again” notables have their own financial ties to the vast and largely unregulated $6.3 trillion global wellness industry that ethicists say raise red flags.

In Rush To Satisfy Trump, GOP Delivers Blow to Health Industry

The health industry couldn’t persuade GOP lawmakers to oppose big Medicaid cuts in President Donald Trump’s tax and spending bill for many reasons. A big one: Congressional Republicans were more worried about angering Trump than a backlash from hospitals and low-income constituents back home.

Who’s Policing Opioid Settlement Spending? A Crowdsourced Database Might Help

Billions in opioid settlement money was meant to be spent on treating and preventing addiction — but what happens if it’s misspent? Some advocates say attorneys general need to pay closer attention. If they don’t, a new tool might empower the public.